EQS-News: Evotec SE
/ Key word(s): Miscellaneous
Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
The issuer is solely responsible for the content of this announcement.
Hamburg, Germany, 07 February 2023:
Prof. Dr Iris Löw-Friedrich, Chairperson of Evotec’s Supervisory Board, said: “Enno Spillner has been essential for Evotec’s rapid, yet sustainable growth over the past years and contributed substantially to the Company’s success story. I understand Enno’s wish to take on a new challenge and on behalf of the entire Supervisory Board, I would like to express our sincere gratitude and wish him all the very best for his personal and professional future. At the same time, we are excited to welcome Laetitia Rouxel as Evotec’s new CFO at this important juncture in the Company’s accelerating evolution. We look forward to benefiting from Laetitia’s leadership, her financial expertise and operational experience as she joins the Management Board in driving the company to the next level of growth and excellence.”
Dr Werner Lanthaler, Chief Executive Officer of Evotec, said: “On behalf of the Management Board and the Company, I would like to thank Enno for his most valuable additions. Enno has made many essential contributions to our Company’s mission. He was responsible for several major financings and the successful listing of Evotec’s shares on NASDAQ. We will closely stay in touch, and we wish him ongoing success for his future endeavours. At the same time, I am delighted to welcome Laetitia. With a wealth of experience from blue chip companies across a variety of industries, Laetitia will help further pave the way as Evotec transitions into its next growth phase.”
“I had the great pleasure of supporting and forming this tremendous growth story through many organic and strategic transactions, helping to position Evotec as one of the leading R&D outsourcing platforms within the industry while building long term sustainability and upside potential. I had the privilege of working with a very skilled and highly motivated team as well as management colleagues. I’m grateful for having had this unique opportunity and wish Evotec all the very best”, said Enno Spillner.
Laetitia Rouxel, designated Chief Financial Officer of Evotec SE, commented: “I am thrilled to join the very talented and passionate team of Evotec, a company with a strong sense of purpose to improve disease understanding through data, science and biology. I bring my expertise as CFO in worldwide environments, along with a commitment of high quality in execution. I am looking forward to co-building and further leveraging innovation at Evotec to reach the next stage in its sustainable growth path.”
Laetitia Rouxel has more than 25 years of finance experience in various sectors such as Life Sciences, Food, Cosmetics and Building industry. After graduating from the French Business school “ISG”, she started her career with finance and commercial roles in the Pharma industry at Pfizer and J&J. After working for the French multinational food-products corporation Danone, where she covered various leading Finance positions in multiple regions for R&D, Medical and Baby Nutrition based in France and in the Netherlands, she then joined the beauty company Coty in Switzerland in 2018, where she became divisional CFO, before being nominated Global CFO of Wavin, a solutions leader for the building and infrastructure industry.
ABOUT EVOTEC SE
Media Contact Evotec SE:
Hinnerk Rohwedder, Director of Global Corporate Communications, Tel.: +49.(0)151 4070-4843, email@example.com
IR Contact Evotec SE:
07.02.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Manfred Eigen Campus / Essener Bogen 7|
|Phone:||+49 (0)40 560 81-0|
|Fax:||+49 (0)40 560 81-222|
|Listed:||Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq|
|EQS News ID:||1553037|
|End of News||EQS News Service|